Atlas Trials

Molecularly Target Therapy With FORFIRINOX in Advanced or Recurrent Extrahepatic Cholangiocarcinoma and Gallbladder Carcinoma

Clinical trial NCT03768375 · UNKNOWN

Trial details

NCT number
NCT03768375
Sponsor
Shanghai Jiao Tong University School of Medicine
Status
UNKNOWN
Phase
Phase 2
Study type
INTERVENTIONAL
Cholangiocarcinoma of the Extrahepatic Bile DuctGallbladder Cancer
Start date
2016-11-01
Primary completion
2020-12-30
Enrollment
150

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.